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SUPPLEMENTARY NOTES
ABSTRACT
A small subpopulation of drug-and radiation-resistant leukemia is an immediate concern for leukemia patients as this subtype remains the actual cause of morbidity and mortality. Our preliminary results showed that P2Y14 functions in bone marrow to preserve stem progenitor cells from premature senescence/cell death induced by genotoxic stress. As P2Y14 is highly expressed in differentiation resistant leukemia cells, P2Y14 expression in leukemia cells may function in preserving regenerative capacity by constraining cell death/senescence induction. We also found that P2Y14 axis is associated with stem cell mobilization. By providing a mechanistic insight for the roles of P2Y14 in the genotoxic stress-induced injury, directly documenting the effects of P2Y14/UDP-Glc axis on stem cell mobilization, our preliminary results are expected to provide the foundation for an effective treatment to destroy therapy resistant leukemia cells.
Introduction
Although conventional therapy temporarily lessens the burden of the disease, a lingering subpopulation of drug-and radiation-resistant leukemia may regenerate. This small subpopulation of drug-and radiation-resistant leukemia is an immediate concern for leukemia patients as this subtype remains the actual cause of morbidity and mortality.
Nucleotides, once recognized as mere sources of energy, are now recognized as key extracellular messengers that regulate diverse aspects of homeostasis in various physiological and pathophysiological conditions (1) . Extracellular nucleotides exert their actions through interaction with their cognate receptors, purinergic receptors. Purinergic receptors are classified into P1 and P2 receptors, based on their ligand binding and function (2) . The role of P2 receptors as regulators of hematopoiesis has become more evident in recent years (3) (4) Since sublethal radiation has been reported to selectively induce HSC senescence (9), we used this modality to investigate the role of P2Y 14 in IR-induced senescence. LSK cells lacking P2Y 14 showed a markedly increased level of SA-β-Gal activity (p=0.003), indicating that P2Y 14 KO HSPCs are more susceptible to IR-induced senescence ( Mice of the indicated genotypes were exposed to TBI as described. NAC was administered as described in Figure 1 . SA-β-gal activity was determined using C 12 To further test whether IR-induced ROS are indeed responsible for the observed preferential reduction of BM cellularity and LSK cells in P2Y 14 KO mice, WT and KO mice were treated with the ROS scavenger N-acetyl-cysteine (NAC). NAC treatment reduced levels of superoxide in LSK cells (Fig. 3A) and alleviated the IR-induced cell death (Fig. 1) and senescence ( Fig. 2 ) in P2Y 14 deficient LSK cells. This was accompanied with restoration of BM cellularity and LSK cell number (data not shown).
Hyper-radiosensitivity of P2Y 14 KO HSCs may relate to their differential DNA repair capacity. Therefore, we assessed levels of γ-H2AX in WT and P2Y 14 deficient LSK cells before and after IR. Similar levels of DNA damage (at 30 min post-IR) and repair (at 6h post-IR) were detected in P2Y14 KO HSPCs in comparison to WT counterparts (Fig. 4) . This indicates that P2Y14 KO HSPCs respond normally to DNA double-strand breaks (DSB) and repair DNA damage. Taken together, our preliminary results strongly suggest that the presence of P2Y 14 in stem/progenitor cells may determine radio and chemo-resistance of cells. Based on these results, we will continue to investigate whether P2Y 14 axis is associated with therapy resistant leukemia phenotypes using the chimeric mice that we established in Specific Aim 2.
Specific Aim 2: To investigate functional correlation between P2Y14 signaling and therapyresistant leukemia
p38 MAPK has been shown to act downstream of ROS and its activation in HSC can lead to a defect in HSCs (10-11). We thus determined whether P2Y14 KO HSPCs display differential activation of p38 MAPK under genotoxic stress. Since ROS generation occurs within seconds of radiation exposure and persists for 2-5 min post-IR {Leach, 2002 #531}, the activation of p38 MAPK was analyzed at an early time point immediately after TBI. Whereas there was no detectable difference in p38 MAPK activity between WT and KO HSPCs under homeostatic conditions, p38MAPK activity was notably higher in P2Y 14 deficient LSK and SLAM LSK cells following radiation (6 Gy, TBI) (Fig. 5, left) . Of note, p38 MAPK activation was transient as its level returned to near basal control levels about 5h after TBI (data not shown). NAC treatment almost completely abolished the p38 MAPK activation (Fig 5, right panel) . Taken together, our data demonstate that P2Y 14 deficiency confers increased susceptibility to genotoxic stressinduced cell death and senescence in HSPC compartments via the excessive activation of p38 MAPK triggered by IR-induced ROS. Two of five AML samples failed to engraft in NOD-scid IL2Rγ null mice. Three AML samples showed detectable human leukemia cells 8 weeks post-transplantation (Fig. 7) .
Currently, approximately 20 NOD-scid IL2Rγ null mice have been transplanted. To assess whether we indeed transplanted leukemia initiating cells, BM cells from these engrafted recipients were subjected to secondary transplantation. Importantly, the frequency of LSKs in the blood of mice treated with UDP-Glc was similar to that obtained with G-CSF treatment (Fig. 8c) . Furthermore, UDP-Glc acted in synergy with G-CSF to induce LSK mobilization (Fig. 8c) . No animals transplanted with control blood cells (PBS injected) survived to lethal irradiation (data not shown). In contrast, UDP-Glc mobilized cells not only displayed the ability to rescue lethally irradiated recipients but also were far superior to control blood cells in a competitive repopulation assay (Fig. 8d) . UDP-Glc-induced mobilization was not the strain-specific phenomenon, since similar results were obtained using (Fig. 8e) . RANKL promotes HSPC mobilization in part via MMP-9 mRNA upregulation (14) . WT LSKs, but not KO LSKs, showed increased expression (1.7-2.5 fold) of MMP-9 upon UDP-Glc treatment (Fig. 8f) , which is comparable to the fold increase in RANKL treated mice (14) .
As normal HSCs and AML initiating cells are known to share many surface molecule and are supposed to use common mechanisms for their mobilization, these results support our hypothesis leukemia stem cells may use P2Y 14 /UDP-Glc axis for their localiztion in bone marrow. Using chimeric recipient mice that established in Specific Aim 2, we will continue to investigate the mobilization of leukemia cells. 
Conclusion
How leukemia stem cells gained resistance to radiation and chemotheraphy is poorly defined, yet critically determines how leukemia cells tolerate conventional leukemia therapy. Our preliminary results showed that P2Y 14 functions in bone marrow to preserve stem progenitor cells from premature senescence/cell death induced by genotoxic stress.
As P2Y 14 is highly expressed in differentiation resistant leukemia cells, P2Y 14 expression in leukemia cells may function in preserving regenerative capacity by constraining cell death/senescence induction. We also found that P2Y 14 axis is associated with stem cell mobilization. By providing a mechanistic insight for the roles of P2Y 14 in the stress-induced injury, directly documenting the effects of P2Y 14 /UDP-Glc axis on stem cell mobilization, our preliminary results are expected to provide the foundation for an effective treatment to destroy therapy resistant leukemia cells.
